PrEP Access and Coverage Act of 2026

Plain-English Summary: PrEP Access and Coverage Act of 2026

Please note: Because no official bill text or description was provided, this summary is based on what can be reasonably inferred from the bill's title and common legislative patterns around this topic. You should verify the actual bill text before drawing firm conclusions.

Based on its title, this bill would likely address insurance coverage and access to PrEP (pre-exposure prophylaxis) — a prescription medication that, when taken regularly, significantly reduces a person's risk of contracting HIV. The bill appears aimed at making PrEP more accessible and affordable for Americans who could benefit from it, potentially by requiring health insurance plans to cover the drug without out-of-pocket costs to patients.

This legislation would most directly affect people at higher risk for HIV who are currently uninsured, underinsured, or facing high costs for PrEP medications. It could also affect insurance companies, pharmacies, and healthcare providers depending on what specific coverage requirements or access programs the bill establishes. The bill may also address gaps that emerged from recent court rulings that affected mandated PrEP coverage under the Affordable Care Act.

The bill was introduced in the Senate and has been referred to the Committee on Health, Education, Labor, and Pensions (HELP), which is the standard first step in the legislative process. No votes have been taken yet, and the bill would need to pass through committee before advancing further in Congress.

*For the most accurate information, look up the full bill text at Congress.gov.*